MARKET

SDGR

SDGR

Schrodinger, Inc.
NASDAQ
13.13
-0.15
-1.13%
After Hours: 13.32 +0.19 +1.43% 19:47 05/08 EDT
OPEN
13.10
PREV CLOSE
13.28
HIGH
13.21
LOW
12.60
VOLUME
1.78M
TURNOVER
--
52 WEEK HIGH
27.63
52 WEEK LOW
10.95
MARKET CAP
981.08M
P/E (TTM)
-9.3552
1D
5D
1M
3M
1Y
5Y
1D
A Look At Schrödinger (SDGR) Valuation After Earnings Miss And Bunsen AI Co Scientist Launch Plans
Simply Wall St · 17h ago
Analysts Have Lowered Expectations For Schrödinger, Inc. (NASDAQ:SDGR) After Its Latest Results
Simply Wall St · 2d ago
Schrodinger posts corporate presentation on computational platform for drug and materials discovery
PUBT · 3d ago
Schrödinger (SDGR) Q1 Loss Of US$60 Million Reinforces Profitability Skepticism
Simply Wall St · 3d ago
Evan Seigerman Reiterates Buy on Schrödinger as Software Expansion and Partnered Successes Strengthen Long-Term Growth Outlook
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Contineum Therapeutics, Inc. Class A (CTNM) and Schrodinger (SDGR)
TipRanks · 4d ago
Buy Rating Reiterated on Operational Progress, Higher-Margin Shift, and Strengthened Balance Sheet; $20 Price Target Unchanged
TipRanks · 4d ago
Schrödinger Earnings Call: Growth Now, Profits Later
TipRanks · 4d ago
More
About SDGR
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.

Webull offers Schrodinger Inc stock information, including NASDAQ: SDGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SDGR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SDGR stock methods without spending real money on the virtual paper trading platform.